• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Histopathology . Clinicopathologic Findings in COVID-19-Associated Ischemic Enterocolitis

tetano

Editor, Senior Moderator
Histopathology


. 2021 Jul 22.
doi: 10.1111/his.14457. Online ahead of print.
Clinicopathologic Findings in COVID-19-Associated Ischemic Enterocolitis


M Lisa Zhang[SUP] 1 2 [/SUP], Frank Jacobsen[SUP] 3 [/SUP], Brian J Pepe-Mooney[SUP] 2 4 5 [/SUP], Mari Mino-Kenudson[SUP] 1 2 [/SUP], Vikram Deshpande[SUP] 1 2 [/SUP], Angela R Shih[SUP] 1 2 [/SUP], Anthony R Mattia[SUP] 1 2 6 [/SUP], Wolfram Goessling[SUP] 2 4 5 7 [/SUP], John O Hwabejire[SUP] 2 8 [/SUP], George C Velmahos[SUP] 2 8 [/SUP], Joseph Misdraji[SUP] 1 2 [/SUP]



Affiliations

Abstract

Aims: Coronavirus disease 2019 (COVID-19) has been recognized as a predominantly respiratory tract infection, but some patients manifest severe systemic symptoms/coagulation abnormalities. We evaluated the impact of severe COVID-19 infection on the gastrointestinal tract.
Methods and results: We examined clinicopathologic findings in 28 resected ischemic bowels from 22 patients with severe COVID-19. Most patients required intubation preoperatively and presented with acute decompensation shortly before surgery. D-dimer levels were markedly elevated in all measured cases (mean: 5394 ng/mL). Histologically, 25 cases (19 patients) showed evidence of acute ischemia with necrosis. In this group, the most characteristic finding was the presence of small vessel fibrin thrombi (24/25 cases, 96%), which were numerous in 64% of cases. Compared to a control cohort of 35 non-COVID-19-related acute ischemic bowels, patients with COVID-19 were significantly more likely to show isolated small intestine involvement (32% vs. 6%, p<0.001), small vessel fibrin thrombi (100% vs. 43%, p<0.001), submucosal vessels with fibrinous degeneration and perivascular neutrophils (90% vs. 54%, p<0.001), fibrin strands within submucosal vessels (58% vs. 20%, p=0.007), and histologic evidence of pneumatosis (74% vs. 34%, p=0.010). Three cases in this cohort had histopathologic findings normally seen in the setting of chronic ischemia, notably prominent fibroblastic proliferation affecting the outer layer of the muscularis propria.
Conclusions: Herein, we describe the histopathologic findings in COVID-19-associated ischemic bowel and postulate a relationship to the hypercoagulable state seen in patients with severe COVID-19 infection. Additional experience with these cases may further elucidate specific features or mechanisms of COVID-19-associated ischemic enterocolitis.

Keywords: COVID-19; fibrin thrombi; gastrointestinal; ischemic enterocolitis; microthrombi.
 
Back
Top Bottom